title: [Myocardial infarction after paclitaxel use].
authors.forename: Nursen
authors.initials: N
authors.lastname: Mersin
authors.forename: Fatia
authors.initials: F
authors.lastname: Boulbair
authors.forename: Siamak
authors.initials: S
authors.lastname: Davani
authors.forename: Michèle
authors.initials: M
authors.lastname: Hehn
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Kantelip
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects*; D010534:Peritoneal Neoplasms / Q000188:drug therapy / Q000556:secondary; D012770:Shock, Cardiogenic / Q000209:etiology
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D016190:Carboplatin; D017239:Paclitaxel